JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by HAYES, A.
Right arrow Articles by COOPER, R. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by HAYES, A.
Right arrow Articles by COOPER, R. G.
Journal of Pharmacology And Experimental Therapeutics, Vol. 176, Issue 2, 302-311, 1971
Copyright © 1971 by American Society for Pharmacology and Experimental Therapeutics

STUDIES ON THE ABSORPTION, DISTRIBUTION AND EXCRETION OF PROPRANOLOL IN RAT, DOG AND MONKEY

A. HAYES 1 and R. G. COOPER 1

1 Biochemistry Department, Imperial Chemical Industries Limited, Pharmaceuticals Division, Alderley Park, Macclesfield, Cheshire, United Kingdom

14C-Propranolol was Completerly absorbed after p.o. dosing to rats and dogs and at least 70% in monkeys. The plasma half-life was approximately 45 minutes in dog after both i.v. and P.O. administration but was of the order of 6 hours in a monkey dosed p.o. at 4.4 mg/kg, peak blood levels of propranolol and 4-hydroxypropranolol being observed at approximately 1 hour after p.o. dosing. Excretion of radioactivity was almost completely via the urine in monkey but rats and dogs excreted approximately 25% via the feces. The fecal excretion was shown to be the result of biliary excretion in rat and dog. Biliary excretion was also shown in monkey, but presumably there must be enterohepatic circulation in this species. Extensive metabolism was shown to occur and the presence of the active 4-hydroxy-propranolol in blood after p.o. dosing was shown. Naphthoxylactic acid was shown to be an important metabolite in the three species. A slightly basic major metabolite was observed in both blood and urine of all the species studied. Propranolol was concentrated in the lung and, to a lesser extent, in brain, liver, kidney and heart; after p.o. dosing each of these tissues probably contained approximately 25% of the apparent propranolol as the 4-hydroxy derivative. Similar concentration of the major metabolite in tissues was not observed.

Submitted on January 5, 1970
Accepted on October 15, 1970




This article has been cited by other articles:


Home page
 Drug Metab. Dispos.Home page
J.-F. Marier, V. Pichette, and P. du Souich
Stereoselective Disposition of Propranolol in Rabbits. Role of Presystemic Organs and Dose
Drug Metab. Dispos., February 1, 1998; 26(2): 164 - 169.
[Abstract] [Full Text]

Home page
 J CARDIOVASC PHARMACOL THERHome page
V. Panagia, Y. Taira, G. L. Bryson, P. S. Tappia, and N. S. Dhalla
Effect of {beta}-Adrenoceptor Antagonists on Phospholipid N-Methylation Activities of Cardiac Sarcolemma
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1998; 3(3): 239 - 245.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1971 by the American Society for Pharmacology and Experimental Therapeutics.